Abstract:Kringle 5(K5) is the fifth kringle domain of human plasminogen and its anti-angiogenic activity is more potent than angiostatin that includes the first four kringle fragment of plasminogen. Our recent study demonstrated that K5 suppressed hepatocarcinoma growth by anti-angiogenesis. To find high efficacy and minimal peptide sequence required for the anti-angiogenic and anti-tumour activities of K5, two deletion mutants of K5 were generated. The amino acid residues outside kringle domain of intact K5 (Pro452-Ala542) were deleted to form K5mut1(Cys462-Cys541). The residue Cys462 was deleted again to form K5mut2(Met463-Cys541). K5mut1 specifically inhibited proliferation, migration and induced apoptosis of endothelial cells, with an apparent two-fold enhanced activity than K5. Intraperitoneal injection of K5mut1 resulted in more potent tumour growth inhibition and microvessel density reduction than K5 both in HepA-grafted and Bel7402-xenografted hepatocarcinoma mouse models. These results suggested that K5mut1 has more potent anti-angiogenic activity than intact K5. K5mut2, which lacks only the amino terminal cysteine of K5mut1, completely lost the activity, suggesting that the kringle domain is essential for the activity of K5. The activity was enhanced to K5mut1 level when five acidic amino acids of K5 in NH(2) terminal outside kringle domain were replaced by five serine residues (K5mut3). The shielding effect of acidic amino acids may explain why K5mut1 has higher activity. K5, K5mut1 and K5mut3 held characteristic β-sheet spectrum while K5mut2 adopted random coil structure. These results suggest that K5mut1 with high efficacy is the minimal active peptide sequence of K5 and may have therapeutic potential in liver cancer.

Construction, Expression, and Purification of Active Human Plasminogen Mutant GST-K5M5 from E.coli

Construction,Expression and Purification of Human Plasminogen Kringle 5 Mutant Ⅰ in E.coli

Cloning Construction and Purification of Recombinant Human Plasminogen Kringle 5 Gene

Optimal Expression and Activity Detection of Human Plasminogen Mutant Kringle 5 in E.coli

Construction of Recombinant Human Plasminogen Kringle5 Baculovirus Vector and Secreted Expression in Myoblast

Expression Of Biologically Active Kringle 5 Domain Of Human Plasminogen In Escherichia Coli

Conruction of Recombinatn Human Plasminogen Kringle5 Baculovirus Vecotr and Secreted Expression in Myoblast

Isolation and Purification of Recombinant Human Plasminogen Kringle 5 by Liquid Chromatography and Ammonium Sulfate Salting-Out.

Construction of Recombinant Adenovirus Carrying Mutant Human Plasminogen Kringle 5 Gene and Expression of K5 Protein

Human Plasminogen Kringle 5 Cdna Clone with Eukaryotic System and Identification of Its Expression Product

Construction and Expression of Eukaryotic Expression Vector for Recombinant Human Plasminogen Kringle 5 Gene

Expression and Its Activity of hPgnK5 Protein in Prokaryotic System

Expression And Characterization Of Kingle 1-5 Domains Of Human Plasminogen

Expression,purification and Identification of Kringle Domain Deletion Mutant of Human Plasminogen in Pichia Pastoris

Expression and Characterization of Kringle 1-4.5 Domains of Human Plasminogen

Expression of Human Plasminogen Kringle 5 As Fusion Protein with Truncated Hifnγ Gene in Escherichia Coli

Anti-angiogenic Activity of Plasminogen Kringle 5 Depending on Its Intact Kringle Domain

High level expression of kringle 5 fragment of plasminogen in Pichia pastoris

[Construction of Recombinant GST-RCAS1 Fusion Gene and Its Expression in E. Coli].

High Efficacy and Minimal Peptide Required for the Anti-Angiogenic and Anti-Hepatocarcinoma Activities of Plasminogen K5.

Study on Cloning, Expression and Function of Recombinant Human Plasminogen Serine Protease Activating Region Gene